Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature
出版年份 2023 全文链接
标题
Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume -, Issue -, Pages -
出版商
Informa UK Limited
发表日期
2023-11-01
DOI
10.1080/14740338.2023.2278686
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meta‐analysis: Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis
- (2023) Carlos Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- OP15 Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
- (2023) S Danese et al. Journal of Crohns & Colitis
- The Role of the Microbiome in the Etiology of Inflammatory Bowel Diseases
- (2023) Ariel Halper-Stromberg et al. Clinics in Colon and Rectal Surgery
- Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding
- (2023) Robyn Laube et al. GUT
- Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
- (2022) Steven R. Ytterberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database
- (2022) Uma Mahadevan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
- (2022) Sailish Honap et al. Frontline Gastroenterology
- Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
- (2022) Bruce E Sands et al. LANCET
- European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation
- (2022) Joana Torres et al. Journal of Crohns & Colitis
- Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project
- (2022) Maria Antonietta Barbieri et al. Biomedicines
- Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis
- (2021) Robyn Laube et al. Expert Opinion On Drug Safety
- Five-year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: the IM-UNITI trial
- (2021) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases
- (2021) Joseph Meserve et al. GASTROENTEROLOGY
- Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry
- (2021) María Chaparro et al. Journal of Crohns & Colitis
- Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
- (2021) Yanna Ko et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
- (2021) Mathurin Fumery et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- One-year effectiveness and safety of ustekinumab in Ulcerative Colitis: a multicenter real-world study from Italy
- (2021) Michele Francesco Chiappetta et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety of drugs used for the treatment of Crohn’s disease
- (2019) Aviv Pudipeddi et al. Expert Opinion On Drug Safety
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation
- (2010) Pauline L. Martin et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now